Clinical Trial: A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07094516) titled 'A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease' on July 23.

Brief Summary: This is a multicentre, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in participants with early AD followed by an Extension. The double-blind part is 72 weeks long, followed by an extension.

Study Start Date: Sept. 18

Study Type: INTERVENTIONAL

Condition: Alzheimer's Disease

Intervention: BIOLOGICAL: VHB937

VHB937 solution for infusion

BIOLOGICAL: VHB937

VHB937 solution for infusion

OTHER: Placebo

Solution for infusion

Recrui...